1. Epigenetics Apoptosis Immunology/Inflammation NF-κB Metabolic Enzyme/Protease
  2. Histone Methyltransferase Apoptosis Reactive Oxygen Species (ROS)
  3. NSD2/H3K36me2 modulator-1

NSD2/H3K36me2 modulator-1 是一种口服有效的 NSD2/H3K36me2 调节剂。NSD2/H3K36me2 modulator-1 与 NSD2 的 SAM 口袋竞争性结合,有效抑制 NSD2 表达并抑制 H3K36me2 甲基化。NSD2/H3K36me2 modulator-1 还能逆转上皮-间质转化 (EMT),抑制细胞迁移,并诱导 G0/G1 期阻滞和细胞凋亡 (apoptosis)。NSD2/H3K36me2 modulator-1 可降低线粒体膜电位 (MMP) 并导致活性氧 (ROS) 生成。NSD2/H3K36me2 modulator-1 可用于研究靶向 NSD2 的表观遗传抗癌策略在肝细胞癌 (HCC) 中的应用。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

NSD2/H3K36me2 modulator-1

NSD2/H3K36me2 modulator-1 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

NSD2/H3K36me2 modulator-1 is an orally active NSD2/H3K36me2 modulator. NSD2/H3K36me2 modulator-1 competitively binds to the SAM pocket of NSD2, potently inhibits NSD2 expression and suppresses H3K36me2 methylation. NSD2/H3K36me2 modulator-1 reverses epithelial-mesenchymal transition (EMT), inhibits cell migration, and induces G0/G1 phase arrest and apoptosis. NSD2/H3K36me2 modulator-1 induces decreased Mitochondrial membrane potential (MMP) and subsequent Reactive oxygen species (ROS) generation. NSD2/H3K36me2 modulator-1 can be used to research the NSD2-targeting epigenetic anticancer strategies for hepatocellular carcinoma (HCC)[1].

IC50 & Target[1]

NSD2

 

体外研究
(In Vitro)

NSD2/H3K36me2 modulator-1 (Compound 5b) (24 小时) 对所有五种癌细胞系均显示出 IC50 < 5 μM 的抑制活性 (在 A549, HepG-2, PC-3, HCT-116 和 MCF-7 细胞中的 IC50 值分别为 4.67, 2.12, 2.64, 4.56 和 4.99 μM),证实了其卓越的广谱抗肿瘤活性[1]
NSD2/H3K36me2 modulator-1 对 HepG-2 细胞的肿瘤选择性高于 HaCaT 细胞 (IC50 = 19.2 μM) (选择性指数 (SI) = 9.06)[1]
NSD2/H3K36me2 modulator-1 (2 μM, 24 小时, 37-62 ℃) 能有效结合 HepG-2 细胞内的 NSD2[1]
NSD2/H3K36me2 modulator-1 (2, 4 μM, 24 小时) 抑制 NSD2 并选择性下调 HepG-2 细胞中 NSD2 介导的 H3K36me2[1]
NSD2/H3K36me2 modulator-1 (2, 4 μM, 24 小时) 在分子水平上逆转 EMT,这可能是通过抑制 NSD2 并随后下调 TWIST1 实现的,从而导致上皮-间质转化 (EMT) 关键调控因子的表达改变[1]
NSD2/H3K36me2 modulator-1 (2, 4 μM, 18, 36 小时) 显著抑制 HepG-2 细胞的迁移和增殖[1]
NSD2/H3K36me2 modulator-1 (2, 4 μM, 24 小时) 对 HepG-2 细胞具有多种调节作用,包括有效诱导细胞凋亡、触发浓度依赖性的 G0/G1 期阻滞、剂量依赖性地降低线粒体膜电位 (MMP) 以及有效促进 ROS 的产生[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: HepG-2 cells
Concentration: 2, 4 μM
Incubation Time: 24 h
Result: Suppressed NSD2 expression in a dose-dependent manner, with notably strong inhibition at 4 μM.
Exhibited high selective inhibition of H3K36me2.
Bound effectively to NSD2 within cells.

Apoptosis Analysis[1]

Cell Line: HepG-2 cells
Concentration: 2, 4 μM
Incubation Time: 24 h
Result: Significantly increased the total apoptosis rate in HepG-2 cells with the elevation of the concentration.
Exhibited slightly superior apoptosis-inducing capacity at the concentration of 4 μM.

Western Blot Analysis[1]

Cell Line: HepG-2 cells
Concentration: 2, 4 μM
Incubation Time: 24 h
Result: Significantly suppressed TWIST1 expression.
Dose-dependently downregulated N-Cadherin and Vimentin.
Upregulated E-Cadherin and Occludin in a dose-dependent manner.

Cell Cycle Analysis[1]

Cell Line: HepG-2 cells
Concentration: 0, 2, 4 μM
Incubation Time: 24 h
Result: Elevated the proportion of HepG-2 cells in G0/G1 phase from 53.8 % to 65.7 %, with the concentration increasing from 0 to 2 μM.
Increased the G0/G1 subpopulation to 79.6 %, with the concentration reaching 4 μM, and exceeded that of 5-Fluorouracil (HY-90006) (73.5 %).
Induced a marked decrease in the levels of cell cycle regulators CDK2, CDK4, and CDK6, effectively blocking cell cycle progression in a concentration-dependent manner.
体内研究
(In Vivo)

NSD2/H3K36me2 modulator-1 (Compound 5b) (20, 40 mg/kg,每日口服,连续 18 天) 在 HepG-2 细胞异种移植模型中表现出强大的抗肿瘤作用,有效抑制肿瘤生长,且安全性良好,这体现在体重、器官指数和形态特征方面没有显著差异[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: An HepG-2 xenograft model established in female BALB/c nude mice (6-8 weeks old)[1]
Dosage: 20, 40 mg/kg
Administration: daily oral gavage (p.o.) for 18 consecutive days
Result: Significantly suppressed tumor growth in a dose-dependent manner.
Exhibited the strongest antitumor effect at 40 mg/kg.
分子量

695.37

Formula

C41H59ClN2O5

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
NSD2/H3K36me2 modulator-1
目录号:
HY-179427
需求量: